Study
Microglial dysfunction linked to cognitive decline in Parkinson’s.
In plain language
Use the full description to understand the study design, methods, and the limits of the findings.
This research investigates how deficiency in TREM2, an immune receptor gene, worsens neuroinflammation and cognitive decline. The study provides insights into the role of microglial function in neurodegeneration and potential therapeutic targets for conditions like Alzheimer's disease.
Open the original publication for the complete methods, outcomes, and source material.
Published October 2025
Opens at the publisher · external site · may require institutional access
The study provides valuable insights into the role of TREM2 in neuroinflammation and cognitive decline, but its preclinical nature limits direct applicability to seniors. Methodological details are not fully accessible, affecting transparency and bias control assessment.
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 5.0/10 | |
| Bias & Methods | 3.3/10 | |
| Statistical Integrity | 5.0/10 | |
| Transparency | 5.0/10 | |
| Conflict of Interest Disclosure | 5.0/10 | |
| Replication / External Validation | 5.0/10 | |
| Relevance to Seniors | 0.0/10 | |
| Journal Quality | 10.0/10 |
Further research in human populations is necessary to confirm these findings and their relevance to senior health.
Build a personalized plan using research-backed studies, conditions, and treatments.